AN ANALYSIS OF PROFITABILITY OF SELECTED INDIAN PHARMACEUTICAL COMPANIES

Abstract

With more than 20,000 registered units the Indian Pharmaceutical sector is highly fragmented. India's pharmaceutical industry meets about 70 per cent of the country 's demand for bulk medicines, pharmaceutical ingredients, additives, pills, capsules, orals, and injection. There are two major things coming out, first, Indian Pharmaceutical Industry is increasing in production, value, volume, number of units-steadily and resembling the entire Indian Economy growth story. Second, the very fundamental pharmaceutical market structure in India is undergoing a big change. By issuing the patent ordinance, as of 1 January 2010, India fulfilled a WTO promise to accept international product patents, the culmination of 10-year process. The Indian Pharmaceutical manufacturers will not be able to produce patented drugs in this new scenario, which they have been doing for a long time though through another method. This study was conducted for critical evaluation of Indian pharmaceutical industry. Since 2014-10 to 2018-19, the research duration is 10 years to evaluate and compare the profitability performance of leading pharmaceutical firms.